The Journal of Law, Medicine & Ethics has accepted a letter to the editor urging the Accreditation Council for Graduate Medical Education (ACGME) establish a requirement that all residents and fellows who care for patients who use opioids, as well as their core faculty, receive specific training on the treatment of opioid use disorder (OUD).

ASAM submitted its comments on the 2020 Medicare Physician Fee Schedule proposed rule, which focus on the two newly proposed payment bundles for the treatment of opioid use disorder, and a provision of the proposed rule that would permit CMS to revoke or deny Medicare enrollment for physicians and eligible professionals under certain circumstances.

ASAM submitted comments on a Notice of Proposed Rulemaking (NPRM) regarding Confidentiality of Substance Use Disorder Patient Records which would expand the ability of law enforcement to access records protected by 42 CFR Part 2.

Physician leaders and other clinicians from the American Society of Addiction Medicine ASAM converged on Capitol Hill today to call on members of Congress to take bold, swift steps to reverse the course of the addiction and overdose crisis in the US by supporting key legislation that would close the gap in teaching, standardizing and covering addiction medicine.

ASAM joined 47 other organizations in urging Congress to oppose the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019, which would exempt certain tobacco products from FDA regulation

Penny Mills, ASAM’s Executive Vice President (EVP) and CEO, has decided she will retire at the beginning of June 2020.

ASAM endorses the American College of Medical Toxicology's position statement "Buprenorphine Administration in the Emergency Department."

ASAM sent a letter urging members of Congress to support the Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act), which would place significant restrictions upon flavored tobacco products.